lilly direct pharmacy tirzepatide Compounders lose battle over Eli weight loss drug and FDA shortage list Zepbound raises profile of Lilly's

Z.HeS.HuangX

How slower digestion affects your microbiome These medications dont just slow the stomach down they can also reduce movement through the small intestine

Semaglutide as a GLP-1 agonist: A breakthrough in obesity treatment

Mounjaro was shown to produce up to 22.5% of body fat reduction and semaglutide (the generic name for Wegovy and Ozempic) resulted in body fat reductions of up to 15%

27(4):921 to 930., Review article by the founder of the field

The Medicare pivot of 2026 For most of the drugs history, Medicare was legally barred from covering weight-loss medications a rule inherited from the 2003 legislation that created Medicare Part D, when the memory of fen-phen and other appetite suppressants made lawmakers wary